Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
ONWARD Medical NV
ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility
26 mars 2025 02h30 HE
|
ONWARD Medical NV
ONWARD Medical Announces First-in-Human Use of ARC-IM
Lumbar Lead Designed to Restore Standing, Stepping, and
Lower Limb Mobility
ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast
19 mars 2025 02h30 HE
|
ONWARD Medical NV
ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast
ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense
04 mars 2025 01h30 HE
|
ONWARD Medical NV
ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense
ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy
25 févr. 2025 01h30 HE
|
ONWARD Medical NV
ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy
ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms
29 janv. 2025 01h30 HE
|
ONWARD Medical NV
ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms
ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
13 janv. 2025 01h30 HE
|
ONWARD Medical NV
ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ONWARD Medical Announces First Commercial Sales of ARC-EX System
09 janv. 2025 01h30 HE
|
ONWARD Medical NV
ONWARD Medical Announces First Commercial Sales of
ARC-EX System
ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chronique de la moelle épinière
19 déc. 2024 11h58 HE
|
ONWARD Medical NV
CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014)Le système ARC-EX® est la première et unique technologie...
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury
19 déc. 2024 11h58 HE
|
ONWARD Medical NV
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System
ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability
12 déc. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability